Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Myovant On Path To Women’s Health Leadership, CEO Says

Executive Summary

CEO Lynn Seely talked during a fireside chat at the BIO CEO & Investor meeting about her company’s strategy to build a new women’s health company and even best big pharma rivals.

Advertisement

Related Content

Myovant CEO Says Buoyant IPO Reflects High Interest In Women's Health
Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology
Takeda Continues To Shed Pipeline Assets In Roivant Deal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register